The Year 2023 in Review

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Average (ratings)

No ratings

•

Your rating

In this week's Parallax podcast, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.

Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.

Drs Kalra and Nijjer share their perspectives and experiences, offering valuable insights, practical tips and considerations when interpreting this year’s most impactful trials:

•    ORBITA-2 (AHA Scientific Sessions): PCI for stable angina
•    FIRE (ESC Congress): Functional versus culprit-only revascularization in elderly patients with myocardial infarction and multivessel disease
•    DAPA-MI (AHA Scientific Sessions): SGLT2i in MI without diabetes or heart failure
•    ILUMIEN IV (ESC Congress): OCT vs angiography-guided PCI
•    OCTOBER (ESC Congress): OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions
•    ARTESIA (ESC Congress): Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
•    SELECT (AHA Scientific Sessions): Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

What are the most impactful cardiovascular trials of 2023? How do Dr Kalra and Dr Nijjer integrate the latest information into their daily practices?

Catch the video version with slides by clicking here.

Read MoreRead Less

Audio Video

Episodes

Up Next

EP 106: Transforming Health Systems Through Economics with Dr Alex Carter

EP106 • Jan 29, 2024 • 47m 1s

The podcast embarks on an exploration of the program's three fundamental pillars: health economics, outcomes measurement, and management. Dr. Carter underscores the importance of efficiently allocating scarce resources, evaluating health system performance through population outcomes, and translating theoretical knowledge into practical application through leadership.

All Episodes

Ep 158: Leading the Structural Heart Revolution: Innovation, Data, and the Future of Valve Therapy

EP158 • May 05, 2026 • 47m 4s

In this episode of Parallax, Dr Ankur Kalra speaks with Dr Kendra Grubb (Medtronic) about her journey from cardiac surgery to industry leadership—and how scaling impact is reshaping structural heart care. From Evolut low-risk insights to sex disparities and the future of AI-driven valve therapy, this is a forward-looking conversation you won’t want to miss.

Ep 157: From HFpEF to AF: Dissecting the ACC 2026 Trials That Matter

EP157 • Apr 20, 2026 • 46m 37s

In this episode of Parallax, Dr Ankur Kalra is joined by Dr Michelle Kittleson, Professor of Medicine and Advanced Heart Failure Cardiologist at Cedars-Sinai Medical Center, for a clinically rich breakdown of her standout trial picks from the 2026 ACC Annual Scientific Sessions.

Ep 156: Gravity, the Heart, and POTS: Space Cardiology's Discoveries

Ep 156: Gravity, the Heart, and POTS: Space Cardiology's Unexpected Discoveries

EP156 • Mar 30, 2026 • 39m 47s

In this fascinating episode of Parallax, Dr Ankur Kalra is joined by Dr Benjamin Levine, Director of the Institute for Exercise and Environmental Medicine and a pioneering figure in the field of space cardiology. Together, they explore the remarkable cardiovascular adaptations that occur in microgravity, and what they are teaching clinicians about treating patients on Earth.

Ep 155: Making Every Procedure Safer, Every Patient Count: Bleeding Risk, Sex Differences, and the Future of Structural Heart

EP155 • Mar 16, 2026 • 54m 6s

In this special TIO Congress edition of Parallax, Dr Ankur Kalra is joined by two of interventional cardiology's most influential voices: Professor Roxana Mehran and Professor Nicholas Van Mieghem. The conversation spans the evolution of online medical education, sex-specific differences in cardiovascular disease, and the challenge of translating clinical evidence into everyday practice.

Ep 154: Climate Change and CV Health: From Heat Waves to Heart Risk

Ep 154: Climate Change and Cardiovascular Health: From Heat Waves to Heart Risk

EP154 • Mar 02, 2026 • 29m 37s

In this episode of Parallax, Dr Ankur Kalra speaks with Dr Sameed Khatana, Assistant Professor of Medicine at the University of Pennsylvania and clinical cardiologist at the Philadelphia VA Medical Center. Their conversation examines the growing connection between environmental factors and cardiovascular health.

Ep 153: The 60-Minute Window: Solutions for Faster STEMI Diagnosis

Ep 153: The 60-Minute Window: Engineering Solutions for Faster STEMI Diagnosis

EP153 • Feb 17, 2026 • 36m 31s

In this episode of Parallax, Dr Ankur Kalra welcomes Dr Rakesh Shah, a former interventional cardiologist, Oxford MBA graduate, and founder of DRS.LINQ.

Ep 152: From Risk Factor to Treatment Target: The New Era of Cardiometabolic Medicine

EP152 • Feb 02, 2026 • 38m 33s

In this key episode of Parallax, Dr Ankur Kalra sits down with Prof Naveed Sattar to explore how recent therapeutic breakthroughs are fundamentally reshaping the cardiologist's approach to diabetes management.

Ep 151: Cardiology's 2025 Year in Review with Dr Sukh Nijjer

EP151 • Jan 16, 2026 • 1h 40m 44s

In this highly anticipated annual year-end episode of Parallax, Dr Ankur Kalra welcomes back Dr Sukh Nijjer, an interventional cardiologist in London, for their seventh consecutive year reviewing cardiology's most significant developments.

Ep 150: Building a Legacy in Cardiology: From the NIH to JAMA Cardiology with Robert Bonow

EP150 • Jan 05, 2026 • 50m 44s

In this landmark 150th episode of Parallax marking the start of Season 8, Dr Ankur Kalra welcomes Professor Robert Bonow, Professor of Medicine and Cardiology at Northwestern University and Editor-in-Chief of JAMA Cardiology. This milestone conversation explores the career of one of cardiology's most influential academic leaders and examines how strategic vision, mentorship, and institutional leadership have shaped modern cardiovascular medicine.

Ep 149: The Placebo-Controlled Revolution: Redefining Evidence in Device Trials

EP149 • Dec 19, 2025 • 33m 7s

In this week's episode of Parallax, Dr Ankur Kalra welcomes Prof Rasha Al-Lamee, interventional cardiology consultant and professor of medicine/cardiology at Imperial College London, and deputy editor of JACC. Prof Al-Lamee has transformed interventional cardiology through her pioneering work on the ORBITA trial series and coronary sinus reducer device studies, introducing the paradigm-shifting concept of sham-controlled device trials to the field.